Journal of the American Academy of Dermatology · 2014 · 131 citations · 93 references
MedicineDermatologyOncologyCancer PharmacologyChemotherapyCutaneous OncologyCutaneous NeoplasmsDermatologic Toxicity ManagementDrug-induced Skin ReactionsSkin TumorsTargeted Cancer TherapyTargeted TherapyChemokines In Cutaneous InflammationChemotherapy-induced Dermatologic ToxicityCutaneous Drug ReactionsCutaneous Reactions ManagementTargeted Therapy Pharmacology
93
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman, Axel Hauschild, Caroline Robert et al. · New England Journal of Medicine · 2011 · 7.7K citations · Full text
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty, Igor Puzanov, Kevin B. Kim et al. · New England Journal of Medicine · 2010 · 3.5K citations
Medicine, Oncology, Pharmacology +17
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Christine H. Chung, Beloo Mirakhur, Emily Chan et al. · New England Journal of Medicine · 2008 · 1.5K citations · Full text
Life Sciences, Immunology, Oncology +15
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Aleksandar Sekulić, Michael R. Migden, Anthony E. Oro et al. · New England Journal of Medicine · 2012 · 1.4K citations · Full text
Medicine, Oncology, Pharmacology +17